Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cholinesterase Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
RIVASTIGMINE 9,123 2,232 24.5% 2,716 300 80.0 yrs 59.5%
DONEPEZIL 8,834 1,101 12.5% 3,963 542 77.2 yrs 59.5%
PYRIDOSTIGMINE 1,965 144 7.3% 576 149 57.6 yrs 58.5%
GALANTAMINE HYDROBROMIDE 721 12 1.7% 499 77 76.9 yrs 82.5%
NEOSTIGMINE METHYLSULFATE 344 11 3.2% 102 48 44.7 yrs 50.5%
MALATHION 27 0 N/A 4 1 29.4 yrs 77.8%

Head-to-Head Comparisons

RIVASTIGMINE vs DONEPEZIL RIVASTIGMINE vs PYRIDOSTIGMINE RIVASTIGMINE vs GALANTAMINE HYDROBROMIDE RIVASTIGMINE vs NEOSTIGMINE METHYLSULFATE DONEPEZIL vs PYRIDOSTIGMINE DONEPEZIL vs GALANTAMINE HYDROBROMIDE DONEPEZIL vs NEOSTIGMINE METHYLSULFATE PYRIDOSTIGMINE vs GALANTAMINE HYDROBROMIDE PYRIDOSTIGMINE vs NEOSTIGMINE METHYLSULFATE GALANTAMINE HYDROBROMIDE vs NEOSTIGMINE METHYLSULFATE
← Back to Cholinesterase Inhibitor [EPC] Class side effects →